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ABSTRACT: Both 5-aza-2′-deoxycytidine (decitabine) and its primary break-
down product, 2′-deoxyriboguanylurea (GuaUre-dR), have been shown to act as
mutagens and epimutagens that cause replication stress and alter both DNA
methylation and gene expression patterns. As cytosine analogues, both are
expected to be preferentially incorporated into regions of GC skew where runs of
cytosine residues are sequestered on one strand and guanine residues on the other.
Given that such regions have been identiﬁed as sites with the potential for eﬀects
on gene expression and replication stress linked to formation of alternative DNA
secondary structures, it is of interest to determine the inﬂuence that these base
analogues might have on the stability of structures of this kind. Here we report
that incorporation of GuaUre-dR into an i-motif-forming sequence decreases both
the thermal and pH stability of an i-motif despite the apparent ability of GuaUre-
dR to base pair with cytosine.
The nucleoside drug decitabine, 5-aza-2′-deoxycytidine, hasbeen identiﬁed as an epimutagen and a chemotherapeu-
tic.1,2 It has been found to induce fragile sites in DNA, inhibit
DNA methylation, and interact with human DNA methyl-
transferase I (DNMT1) possibly through the formation of a
complex at DNA sites containing 5-aza-2′-deoxycytidine
(5azaC-dR) and 2′-deoxyriboguanylurea (GuaUre-dR).3 As
5azaC-dR is unstable in aqueous environments, there has been
interest in the activity of its breakdown products; 5azaC-dR
readily hydrolyzes to GuaUre-dR2,4 (Figure 1). It has been
shown that GuaUre-dR induces the same eﬀects that are seen
with the parent drug,3 suggesting it may be responsible for
much of the activity observed with 5azaC-dR. GuaUre-dR
contributes to replication stress by sequestering methyltrans-
ferases, inducing hypomethylation and encouraging DNA
instability, much like its precursor.3,5
5azaC-dR has been shown to induce the proteolytic
degradation of DNMT1 but not of DNMT3a or DNMT3b.
While the formation of a covalent bond between DNMT1 and
5azaC-dR-treated DNA could be ruled out as a cause of
proteolysis, the mechanism by which DNMT1 is targeted for
degradation is not yet well understood.6 However, it is known
that noncanonical DNA structures rich in cytosine are targeted
by DNMT1.7 This interaction results in methylated CG
dinucleotides at sites of abnormal base pairing that bind to
and trap the DNMT1 enzyme in tight DNA complexes.8−11 An
interaction with a noncanonical DNA structure, such as a
hairpin or an i-motif (C-quadruplex), could trap the enzyme
and provide an additional trigger for the proteolysis of
DNMT1. Cytosine-rich i-motif and hairpin structures are
dependent on hemiprotonated cytosine:cytosine base pairing,12
and a single sequence can give rise to either morphology or
both in equilibrium depending on the environment.13−15 It has
been proposed that GuaUre-dR can base pair with cytosine in
the absence of protonation;16 this suggests that the presence of
GuaUre-dR in a cytosine-rich sequence may inﬂuence the
stability and type of secondary structure that may form. The
human telomeric i-motif sequence is a well-characterized model
oligonucleotide that has been extensively used as a typical i-
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Figure 1. Structure of the β-form of 5azaC-dR and its hydrolysis
product, the β-form of GuaUre-dR.
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motif structure.17 This sequence was modiﬁed with GuaUre-dR
to determine its eﬀect on the stability of the resultant secondary
structure. Ultraviolet (UV) thermal melting, thermal diﬀerence
spectra, and circular dichroism spectroscopy were used to
characterize the pH and thermal stability of the human
telomeric i-motif sequence with and without GuaUre-dR
modiﬁcation.
■ MATERIALS AND METHODS
Oligonucleotide Synthesis. The methods used in the
synthesis of oligodeoxynucleotides and associated phosphor-
amidites have been described in detail.3 All syntheses were
performed on a 1 μmol scale using a Cyclone Plus DNA
Synthesizer (MilliGen Bioresearch, Novato, CA). In brief, the
syntheses were performed as follows.
Human Telomeric Sequence (hTeloC). Synthesis of the control
sequence was performed using phosphoramidites purchased
from Glen Research (Sterling, VA). Deprotection was
performed with 32% ammonium hydroxide overnight at 55
°C, followed by puriﬁcation using high-performance liquid
chromatography (HPLC) as described previously.3 The
resulting pure fractions were characterized by polyacrylamide
gel electrophoresis and mass spectrometry. The control 24-mer
[5′-TAA-CCC-TAA-CCC-TAA-CCC-TAA-CCC-3′ (hTe-
loC)] had a predicted monoisotopic mass (MS) of 7127.246.
The observed MS was 7127.274, and the predicted MW was
7130.723 g mol−1. The yield of the pure oligodeoxynucleotide
was 2.12 mg (297.3 nmol).
Modif ied Human Telomeric Sequence (hTeloX, X = GuaUre).
As previously noted,3 GuaUre-dR-containing oligodeoxynucleo-
tides are not stable when deprotection is performed with
standard ammonium hydroxide. Consequently, we adopted an
alternative approach using p-nitrophenylethoxycarbonyl pro-
tecting groups for this purpose.3,18 The required phosphor-
amidites were synthesized and characterized as previously
described.3 Each phosphoramidite carried a dimethoxytrityl
group at the 5′ coupling site and a bis(N,N-didisopropylami-
no)-2-(4-nitrophenyl) ethoxyphosphane group at the 3′
coupling site. Primary amines were protected with p-nitro-
phenylethoxycarbonyl groups (Figure 2).
Synthesis of the homologous GuaUre-dR-containing se-
quence with GuaUre-dR = X at position 6 was performed using
phosphoramidites depicted in Figure 2. This position was
selected as previous work19 has shown that epigenetic
modiﬁcation of the cytosines adjacent to a loop changed the
stability of the structure. Deprotection was performed with a
solution of 0.5 M 1,8-diazabicyclo[5.4.0]undec-7-ene in
anhydrous pyridine containing 5 mg/mL thymine for 16 h at
room temperature20 as previously described.3 Deprotection was
followed by puriﬁcation using HPLC as previously described.3
The resulting pure fractions were characterized by polyacryla-
mide gel electrophoresis and mass spectrometry. The GuaUre-
dR-containing 24-mer [5′-TAA-CCX-TAA-CCC-TAA-CCC-
TAA-CCC-3′ (hTeloX)] had a predicted monoisotopic mass
(MS) of 7118.257. The observed MS was 7118.268, and the
predicted MW was 7121.713 g mol−1. The yield of the pure
oligodeoxynucleotide was 513.5 μg (72.1 nmol).
The unmodiﬁed (hTeloC) and modiﬁed (hTeloX) oligonu-
cleotides (ODNs) were dissolved in Milli-Q water to give ﬁnal
concentrations of 100 μM and conﬁrmed using a Nanodrop
Spectrophotometer (LabTech, Heathﬁeld, UK). The extinction
coeﬃcient for the unmodiﬁed control sequence (hTeloC) was
used to calculate the concentration for both sequences. For all
biophysical characterization experiments, ODNs were diluted in
buﬀer containing 10 mM sodium cacodylate and 100 mM
sodium chloride at the pH as detailed, thermally annealed by
heating in a heat block at 95 °C for 5 min, and slowly cooled to
room temperature overnight. To allow comparison, all
experiments were performed in the same buﬀer type, though
some pHs examined were outside the buﬀering capacity of
sodium cacodylate (pH 4.0, 4.5, and 5.0), and control
experiments that examined the pH under the conditions of
the experiment showed little diﬀerence in the overall change in
pH (see Figure S1).
Circular Dichroism (CD). CD spectra were recorded on a
Jasco J-810 spectropolarimeter using a 1 mm path length quartz
cuvette as described previously.21 ODNs were diluted to 10 μM
Figure 2. Structures of phosphoramidites prepared for use in the synthesis of the GuaUre-dR-containing oligodeoxynucleotide: 1, 5′-O-
dimethoxytrityl-3′-O-[2-(4-nitrophenyl)ethoxy-N,N-diisopropyl]-2′-deoxythymidine phosphoramidite; 2, 5′-O-dimethoxytrityl-3′-O-[2-(4-
nitrophenyl)ethoxy-N,N-diisopropyl]-2′-deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]cytidine phosphoramidite; 3, 5′-O-dimethoxytrityl-3′-O-[2-
(4-nitrophenyl)ethoxy-N,N-diisopropyl]-2′-deoxyribofuranosyl-3-guanyl-N,N-bis[2-(4-nitrophenyl)ethoxycarbonyl]urea phosphoramidite; 4, 5′-O-
dimethoxytrityl-3′-O-[2-(4-nitrophenyl)ethoxy-N,N-diisopropyl]-2′-deoxy-N6-[2-(4-nitrophenyl)ethoxycarbonyl]adenosine phosphoramidite. Each
phosphoramidite was characterized prior to use by chromatography, 31P nuclear magnetic resonance, and mass spectrometry as described
previously.3
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(total volume of 200 μL) in buﬀer at pH increments of 0.5 pH
unit from pH 4.0 to 8.0. Additional details are included in the
Supporting Information. The transitional pH (pHT) for the i-
motif was calculated from the inﬂection point of the ﬁtted
ellipticity at 288 nm. Final analysis and manipulation of the data
were performed using Origin 2015 (OriginLab, Northhampton,
MA).
UV Absorption Spectroscopy. UV spectroscopy experi-
ments were performed as described previously.21 Brieﬂy, a Cary
60 UV−visible spectrometer (Agilent Technologies) equipped
with a TC1 Temperature Controller (Quantum Northwest)
was used to measure the absorbance of a 2.5 μM ODN sample
at a speciﬁc pH in a small-volume masked quartz cuvette (1 cm
path length). The absorbance of the ODN was measured at 295
nm as the temperature of the sample was held for 10 min at 4
°C and then increased to 95 °C at a rate of 0.5 °C/min and
held at 95 °C for 10 min before the process was reversed; each
melting/annealing process was repeated three times. Data were
recorded every 1 °C during both melting and annealing, and
each point was the average of three scans. Melting (Tm) and
annealing (Ta) temperatures were determined using the ﬁrst-
derivative method. Additional details are available in the
Supporting Information. Thermal diﬀerence spectra were
calculated by subtracting the spectrum between 220 and 320
nm of the folded structure at 4 °C from that of the unfolded
structure at 95 °C. The data were normalized, and the
maximum change in absorption was set to +1 as previously
described.22
■ RESULTS AND DISCUSSION
The pH and thermal stability of two ODN sequences based on
the human telomeric i-motif were examined to determine the
eﬀect of GuaUre-dR modiﬁcation on i-motif formation. The
control sequence (hTeloC) remained unmodiﬁed, while the
modiﬁed sequence (hTeloX) included GuaUre-dR instead of
cytosine at the last position of the ﬁrst cytosine tract. We used
biophysical techniques to characterize the control and modiﬁed
sequences; CD was used to determine the pHT and UV
spectroscopy to identify the Tm and Ta values under diﬀerent
environmental conditions.
The pH stabilities of hTeloC and hTeloX sequences were
assessed using CD spectroscopy. The spectra were measured at
pH values ranging from 4 to 8. At acidic pH (pH 4.0−5.5), the
modiﬁed and unmodiﬁed sequences showed spectra with classic
i-motif characteristics: a positive peak at ∼288 nm and a
negative peak at ∼255 nm (Figure 3).23 However, the behavior
of the sequences diﬀered at pH 6.0; the hTeloX sequence
spectra shifted to more closely resemble that of a random coil
with a positive peak at 273 nm and a negative peak at 250 nm,
while the hTeloC spectra remained more similar to those of the
i-motif (Figure 3). By pH 6.5, both sequences showed spectra
characteristic of random coil,23 and the calculated pHT values
for hTeloX and hTeloC were 5.8 and 6.1, respectively (Figure
3). This indicated that the substitution of GuaUre-dR for a
cytosine reduced the pH stability of the human telomeric i-
motif-forming sequence.
UV spectroscopy was used to further characterize hTeloC
and hTeloX. The thermal stability of each ODN was assessed
from pH 4.0 to 7.0. Beyond this pH, CD had shown that the
sequences would be unfolded; indeed, the pH 7.0 melting and
annealing curves could not be normalized for either sequence as
they showed no diﬀerences in absorbance between high and
low temperatures (Figures S2B and S3B and Table S1). At pH
4.0−6.0, both ODNs showed two-state (folded and unfolded)
melting and annealing curves (Figures 4, S2, and S3). This was
also true of the modiﬁed hTeloX at pH 6.5. However, the
unmodiﬁed sequence hTeloC showed a three-state UV melting
curve at pH 6.5, resulting in two melting transitions (Figure
4A). This indicated the possibility of two distinct secondary
structures at pH 6.5 and was interesting because the CD results
indicated that at this pH the secondary structure would be
unfolded. A separate study that evaluated the pH stability of the
hTeloC sequence also showed an unfolded CD spectra at pH
6.4 and 6.6,24 which was consistent with the pH stability
reported here. However, only a single value was reported for
the Tm, suggesting only a single transition in the UV melt at a
similar pH.24 We have observed double transitions in i-motif
sequences previously,21 and others have attributed these to an
equilibrium mixture composed of the i-motif and hairpin.14,15
Here, this isolated phenomenon opens an opportunity for
further investigation but does not impact the primary objective
Figure 3. Circular dichroism of (A) the GuaUre-dR-modiﬁed hTeloC
sequence [the inset shows the fraction folded at 288 nm, used to
determine the pHT of hTeloX of 5.83 (adjusted R
2 = 0.997)] and (B)
the unmodiﬁed hTeloC sequence [the inset shows the fraction folded
at 288 nm, used to determine the pHT of hTeloC of 6.11 (adjusted R
2
= 0.998)]: (magenta) pH 4.0, (red) pH 4.5, (orange) pH 5.0, (yellow)
pH 5.5, (light green) pH 6.0, (dark green) pH 6.5, (blue) pH 7.0,
(black) pH 7.5, and (purple) pH 8.0. All oligonucleotide
concentrations were 10 μM in 10 mM sodium cacodylate buﬀer
with 100 mM sodium chloride buﬀer at the required pH.
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of this work. Increasing the pH resulted in a decreased thermal
stability for both hTeloC and hTeloX (Figure 4A and Table
S1). However, hTeloX was less thermally stable than hTeloC;
at pH 4.0, the Tm of hTeloC is 15 °C higher than the Tm for
hTeloX (Figure 4A). This diﬀerence between the Tm of hTeloC
and hTeloX is largest when the absorbance is measured under
pH 5.0 conditions [18 °C (Figure 4B)].
The measurement of thermal diﬀerence spectra (TDS) was
also used to supplement the characterization of the hTeloC and
hTeloX secondary structures. DNA secondary structures absorb
UV light diﬀerently when they are folded and unfolded, and
taking the diﬀerence between these spectra gives an indicative
spectrum that can be used for characterization. TDS were
determined to indicate the dominant folded species of each
ODN at each pH. The resultant diﬀerence spectra are
characteristic of the folded DNA structure present at the
lower temperature.22 At pH 4.0−5.0, the TDS of hTeloX
showed a positive peak at 240 nm and a negative peak at 295
nm (Figure S4). This was consistent with the TDS of the
previously characterized folded human telomeric i-motif.22 This
indicated that the GuaUre-dR-modiﬁed sequence (hTeloX)
was folded into the i-motif structure between pH 4.0 and 5.5.
At higher pHs (6.0−7.0), the TDS were more indicative of
random coil, consistent with the observations using CD
spectroscopy.
Similarly, the TDS of the unmodiﬁed hTeloC indicated a
folded i-motif. As seen in the UV melting experiment, evidence
of a folded i-motif structure (the characteristic positive 240 nm
peak and negative 295 nm peak) was indicated at all the
measured pH values between 4.0 and 6.5. Only at pH 7.0 does
the TDS for hTeloC indicate a random coil structure (Figure
S4).
The biophysical evidence presented here indicates that the
dominant secondary structure assumed by both the unmodiﬁed
(hTeloC) and the GuaUre-dR-modiﬁed (hTeloX) sequence is
an i-motif. The addition of GuaUre-dR instead of a cytosine in
the ﬁrst tract decreases the thermal and pH stability of the
structure, despite its suggested ability to base pair with
cytosine.16 This degree (10 °C) of thermal destabilization
(change in Tm) is consistent with what others have observed
upon mutation of a cytosine, which is known to form C-C base
pairs, to a thymine.25 This suggests that GuaUre may be
interacting with cytosine in a way that does not contribute to i-
motif stability. It may well be that GuaUre can base pair with a
cytosine, just not in the context of an i-motif, but further work
would be required to determine whether this is the case.
While GuaUre-dR has been implicated in the overall activity
of 5azaC-dR through multiple possible mechanisms, an
interaction based on formation of the i-motif is likely more
complicated than ﬁrst thought. DNA secondary structures have
been associated with the regulation of genes, and the i-motif in
particular has been described as a regulatory switch.14,15
Moreover, the cytosine-rich sequences in i-motif-forming
regions have been shown to be preferred sites for R-loop
formation.26 These structures arise when the RNA transcript
base pairs with the template strand during transcription,
dislodging its DNA complement to form a RNA−DNA
hybrid;27 the aﬀected regions on the template have no
complement on the RNA strand and so form single-stranded
bulges. R-Loop formation has been associated with DNA
damage and may contribute to genomic instability.28 Although
the presence of GuaUre-dR in DNA does not inhibit DNA
synthesis in vitro,3 its eﬀects on RNA synthesis and RNA:DNA
hybrid stability are unknown. Even so, it is clear that R-loop
formation is conﬁned to regions of GC skew where 5azaC-dR
and GuaUre-dR are most likely to be found during drug
treatment. Our ﬁndings clearly show that GuaUre-dR
destabilizes i-motif structures; however, biological consequen-
ces of altering the stability of the many structures that can form
in cytosine-rich sequences may have additional, and perhaps
unforeseen, ramiﬁcations in a system as complex as the
interaction between 5azaC-dR and biological molecules.
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Figure 4. (A) Relationship between the pH and the Tm of hTeloC and hTeloX. Tm values were determined using the ﬁrst-derivative method: (■)
hTeloC Tm and (▲) hTeloX Tm. At pH 6.5, the UV melting curve of hTeloC showed two transitions indicating two melting curves. The times sign
indicates the secondary melting temperature, Tm2, of hTeloC at this pH. (B) Normalized UV melting curves of GuaUre-dR-modiﬁed hTeloX and
unmodiﬁed hTeloC sequence at pH 5.0. All oligonucleotide concentrations were 2.5 μM in 10 mM sodium cacodylate buﬀer with 100 mM sodium
chloride buﬀer (pH 5.0).
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Full methodological details, data, and control experi-
ments (PDF)
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